Delivery Order SPE2DB22D2206-SPE2DB25FJM59
- Not listed
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is...
- This federal contract award is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $26,927.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orserdu (orsethamine) 345 mg tablets in a 30-count package under a firm fixed-price contract with a ceiling value of $13,920.91. The award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive delivery order issued without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- This is a $13,920.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 3, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,644.36 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under which the pharmaceutical distributor will supply medical products to support federal healthcare needs. The award leverages AmerisourceBergen's extensive presence...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,191.66 to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order, issued under contract number 4569059988, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $135,070.25 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $27,799.20 from the Defense Logistics Agency's Medical Supply Chain on August 15, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is set to be completed by August 18, 2025, and work will be performed at the vendor's Conshohocken facility. This delivery order...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM59Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This $13,920.91 firm fixed price delivery order, which is scheduled for completion by September 10, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio with the Defense Logistics Agency's Medical Supply Chain. The company demonstrates proven capability to fulfill diverse federal medical procurement requirements through open competition, with contract awards spanning a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies. This delivery order reflects the contractor's ongoing role in supporting Defense Health Agency requirements and broader government healthcare systems through flexible contract vehicles designed to meet military medical supply needs on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 8/19/25 |